- Home
- ECOR vs AAME Comparison
ECOR vs AAME Comparison
Compare ECOR & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- AAME
- Stock Information
- Founded
- ECOR 2005
- AAME 1968
- Country
- ECOR United States
- AAME United States
- Employees
- ECOR N/A
- AAME N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AAME Life Insurance
- Sector
- ECOR Health Care
- AAME Finance
- Exchange
- ECOR Nasdaq
- AAME Nasdaq
- Market Cap
- ECOR 39.7M
- AAME 46.3M
- IPO Year
- ECOR 2018
- AAME N/A
- Fundamental
- Price
- ECOR $7.75
- AAME $2.27
- Analyst Decision
- ECOR Strong Buy
- AAME
- Analyst Count
- ECOR 2
- AAME 0
- Target Price
- ECOR $25.50
- AAME N/A
- AVG Volume (30 Days)
- ECOR 118.8K
- AAME 26.5K
- Earning Date
- ECOR 08-06-2025
- AAME 08-13-2025
- Dividend Yield
- ECOR N/A
- AAME 0.91%
- EPS Growth
- ECOR N/A
- AAME N/A
- EPS
- ECOR N/A
- AAME N/A
- Revenue
- ECOR $26,458,000.00
- AAME $191,355,000.00
- Revenue This Year
- ECOR $23.21
- AAME N/A
- Revenue Next Year
- ECOR $44.10
- AAME N/A
- P/E Ratio
- ECOR N/A
- AAME N/A
- Revenue Growth
- ECOR 41.54
- AAME 2.04
- 52 Week Low
- ECOR $4.47
- AAME $1.25
- 52 Week High
- ECOR $19.49
- AAME $2.61
- Technical
- Relative Strength Index (RSI)
- ECOR 64.43
- AAME 60.63
- Support Level
- ECOR $6.57
- AAME $1.94
- Resistance Level
- ECOR $7.80
- AAME $2.28
- Average True Range (ATR)
- ECOR 0.74
- AAME 0.13
- MACD
- ECOR 0.03
- AAME 0.00
- Stochastic Oscillator
- ECOR 63.97
- AAME 81.82
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.